Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights American Express, Coca-Cola and UnitedHealth

Read MoreHide Full Article

For Immediate Release

Chicago, IL – September 25, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: American Express Co. (AXP - Free Report) , The Coca-Cola Co. (KO - Free Report) and UnitedHealth Group Inc. (UNH - Free Report) .

Here are highlights from Tuesday’s Analyst Blog:

3 Blue-Chip Stocks to Buy as Dow Maintains Northbound Journey

U.S. stock markets have been on an impressive bull run over the past 21 months. However, the Dow, despite participating in the bull run, lagged its peers, the S&P 500 and the Nasdaq Composite. Wall Street's blue-chip index (the Dow) is up 11.7% year to date. On the other hand, the broad-market S&P 500 Index and the tech-heavy Nasdaq Composite have rallied 20.6% and 21.7%, respectively.

However, from mid-August, the Dow has been northbound. At this stage, from an investment perspective, we have narrowed our search to three blue-chip stocks. These are — American Express Co., The Coca-Cola Co. and UnitedHealth Group Inc.

These stocks have strong earnings growth potential for the rest of 2024. These stocks have seen positive earnings estimate revisions in the past 60 days. Each of our picks carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Dow's Momentum Likely to Continue

Last week, the Fed initiated the first cut interest rate since March 2020 with an aggressive reduction of 50 basis points. Unlike last year's technology-driven rally, this year, the bull run is more broad-based.

The anticipation of a Fed rate cut and extremely high valuation of the technology sector, compelled market participants to shift from technology to other rate-sensitive cyclical sectors, such as utilities, industrials, financials, energy, materials and health care.

Dow is more inclined toward cyclical stocks. On Sept. 23, the blue-chip index posted all-time highs of 42,190.05 and 42,124.65 for intraday and closing-basis, respectively. Technically, at its current level of 42,124.65, the Dow is well above its 50-day and 200-day moving averages of 40,645.61 and 39,061.85, respectively.

The 50-day moving average line is generally recognized as a short-term trendsetter in financial literature, while the 200-day moving average is considered a long-term trendsetter. Historically, it has been noticed in the technical analysis space that whenever the 50-day moving average line surges ahead of the 200-day moving average line, a long-term uptrend for an asset (in this case the Dow Index) becomes a strong possibility.

Buy 3 Blue-Chip Stocks for Long-Term Gains

American Express Co.

American Express' growth initiatives, like launching new products, reaching new agreements and forging alliances, are boosting its revenues. Consumer spending on travel and entertainment, which carries higher margins for AXP is advancing well. AXP's solid cash-generation abilities enable the pursuit of business investments and prudent deployment of capital via buybacks and dividends.

AXP Stock's Earnings Estimate Revisions on the Rise

American Express has an expected revenue and earnings growth rate of 9% and 17.1%, respectively, for the current year. The Zacks Consensus Estimate for the current quarter, current year and next year has improved in the past 30 days.

The Coca-Cola Co.

Coca-Cola experiences positive business trends, as evidenced by its strong track record of beating expectations. In the second quarter of 2024, KO exceeded sales and earnings estimates for the sixth consecutive quarter, with both metrics showing year-over-year improvement. Strong revenue growth across most operating segments, supported by improved price/mix and unit volume growth aided results.

KO is well-poised to benefit from innovations and growing digital investments. KO has provided an optimistic view for 2024. We expect organic revenue growth of 10% for 2024, with an 8.3% positive price/mix and a 1.7% rise in concentrate sales.

Strong Earnings Estimate Revisions for KO Shares

Coca-Cola has an expected revenue and earnings growth rate of 0.6% and 6%, respectively, for the current year. The Zacks Consensus Estimate for the current year and next year has improved in the past 60 days.

UnitedHealth Group Inc.

UnitedHealth Group's top line is likely to maintain its momentum on the back of a strong market position, new deals, renewed agreements and expansion of service offerings. UNH's solid health services segment provides diversification benefits. The Government business remains well-poised for growth in the future.

UNH's adjusted net earnings per share are anticipated to be in the $27.5-$28.00 band in 2024. A sturdy balance sheet of UNH enables business investments and prudent deployment of capital via share repurchases and dividend payments.

Solid Earnings Estimate Revisions for UNH Shares

UnitedHealth Group has an expected revenue and earnings growth rate of 7.3% and 10.2%, respectively, for the current year. The Zacks Consensus Estimate for the next quarter, current year and next year has improved in the past 60 days.

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                                   

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


UnitedHealth Group Incorporated (UNH) - free report >>

CocaCola Company (The) (KO) - free report >>

American Express Company (AXP) - free report >>

Published in